Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul 6;98(13):1132-9.
doi: 10.2106/JBJS.16.00299.

Tissue Engineering in Orthopaedics

Affiliations
Review

Tissue Engineering in Orthopaedics

Alexander M Tatara et al. J Bone Joint Surg Am. .

Abstract

➤It is important to carefully select the most appropriate combination of scaffold, signals, and cell types when designing tissue engineering approaches for an orthopaedic pathology.➤Although clinical studies in which the tissue engineering paradigm has been applied in the treatment of orthopaedic diseases are limited in number, examining them can yield important lessons.➤While there is a rapid rate of new discoveries in the basic sciences, substantial regulatory, economic, and clinical issues must be overcome with more consistency to translate a greater number of technologies from the laboratory to the operating room.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The orthopaedic tissue engineering paradigm.
Fig. 2
Fig. 2
Overview of the classes of scaffolds.

Similar articles

Cited by

References

    1. Henkel J, Woodruff MA, Epari DR, Steck R, Glatt V, Dickinson IC, Choong PF, Schuetz MA, Hutmacher DW. Bone regeneration based on tissue engineering conceptions—a 21st century perspective. Bone Res. 2013. September;1(3):216-48. Epub 2013 Sep 25. - PMC - PubMed
    1. Hogan MV, Walker GN, Cui LR, Fu FH, Huard J. The role of stem cells and tissue engineering in orthopaedic sports medicine: current evidence and future directions. Arthroscopy. 2015. May;31(5):1017-21. Epub 2015 Feb 25. - PubMed
    1. Davies BM, Rikabi S, French A, Pinedo-Villanueva R, Morrey ME, Wartolowska K, Judge A, MacLaren RE, Mathur A, Williams DJ, Wall I, Birchall M, Reeve B, Atala A, Barker RW, Cui Z, Furniss D, Bure K, Snyder EY, Karp JM, Price A, Carr A, Brindley DA. Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: a pilot study. J Tissue Eng. 2014;5:2041731414551764. Epub 2014 Sep 19. - PMC - PubMed
    1. Madry H, Alini M, Stoddart MJ, Evans C, Miclau T, Steiner S. Barriers and strategies for the clinical translation of advanced orthopaedic tissue engineering protocols. Eur Cell Mater. 2014;27:17-21; discussion 21. Epub 2014 May 6. - PubMed
    1. Niemansburg SL, van Delden JJ, Oner FC, Dhert WJ, Bredenoord AL. Ethical implications of regenerative medicine in orthopedics: an empirical study with surgeons and scientists in the field. Spine J. 2014. June 1;14(6):1029-35. Epub 2013 Nov 1. - PubMed